RE:Catalysts In Q1RVV suffered this last down turn with about 80% of every other stock on the market. These highly speculative and very risky biotechs normally get hammered with the market x2.
If you are in this hoping on trial positive results I have some bad news for you. Getting a great P value in a trial is not an easy thing to do. This is why biotechs have such great reward when they are winners.
The most likely valye here is with Mushrooms, RVV has a bit of market here that can lead to grown or a buyout.
The share price will recover. Risk a portion of your position and try to flip the dips.
Key word: RISK.
Target: $1.81 on mushroom IP alone
with BUC x2